How's the Capital Raise Going to Work?, page-2

First 2 Last

Share
Profile

Follow
dalts66

4,675 Posts.

2153

15/03/23

10:31

Post #: 66772708
Share

Originally posted by fourdollars: ↑

CHM is burning around $5m per quarter. Even with the recent R&D tax rebate, it has less than 2 quarters of funding remaining.

The L1 facility requires that CHM issues shares at a discount to the VWAP of 5 of the previous 30 trading days (selected by L1), so whatever the exact price, its looking like it will be under 7cps.

Current shares on issue: 437m

Raising $30m at 7cps = 429m shares. Plus L1 were already issued 5m shares back in June last year when the funding arrangement was announced. This would leave L1 with approx 50% of the company. I don't think any shareholder can take such a large position without the approval of other shareholders, so not sure how this can work?

The L1 funding agreement announcement did note: "Equity placement facility of up to a total of A$30 million over 24 months with L1 Capital ..... by way of separate placements (the size of whichare subject to certain limits)"

Maybe this is what the clause alludes to - ie there are certain limits to the number of shares that can be issued.

But even if this was capped to under 20% of the company, over 100m shares would still be issued to L1. This would only raise $7m, and not even cover a further 2 quarters of cashburn at CHM. Also, there is the possibility that L1 won't feel comfortable owing such a large percentage of CHM, leading to SP pressure as it reduces its position.

So does Hopper pursue the usual Bell Potter / sophisticated biotech investor route, where he issues discounted shares to nameless entities along with millions of free options? Its been his modus operandi at Imugene, but the last two capital raises there are so far under water it might not be an easy sell here. Might require issuing shares at a massive discount (sub 4c?), and possibly also result is a significant share overhang that puts further downward pressure on the SP.

Hard to see how CHM can be funded for much longer without a huge dilution ....

Expand

If the readout of the 3rd cohort shows promise of disease control or better. we may have the 1st CarT drug that can tackle solid tumour cancer.

That may be the catalyst you are looking for. Remember that the NK trial underway now is of no cost to CHM.

Luckily CHM is run by a group of highly experienced folk. This is not their first rodeo.With the tiny SOI now, and incredibly low market cap for its pipeline. even with dilution now, thd potential of many multiples of upside is still available.

CHM Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
14 Upvote

2 Great analysis

Reply

Top Stories

Tuesday's HotCopper trends: Paradigm funding, Nanoveu drone gains | July 1

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

TRS

Don't cry that it's over: The Reject Shop shares to disappear on Wednesday

ENR

Encounter's Aileron recon success 'illustrates how much more still to be found'

AII

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

There are more pages in this discussion • 19 more messages in this thread...

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.001(12.5%)		Mkt cap ! $9.068M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$2.418K	526.2K

Buyers (Bids)

No.	Vol.	Price($)
12	11217085	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	15687025	18

View Market Depth

No.	Vol.	Price($)
12	11217085	0.004
40	26959271	0.003
17	16400505	0.002
12	54150000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	15687025	18
0.006	11718229	12
0.007	3350000	3
0.008	8685291	7
0.009	1149101	3

Last trade - 15.52pm 01/07/2025 (20 minute delay)

CHM (ASX) Chart

How's the Capital Raise Going to Work?, page-2

Tuesday's HotCopper trends: Paradigm funding, Nanoveu drone gains | July 1

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Don't cry that it's over: The Reject Shop shares to disappear on Wednesday

Encounter's Aileron recon success 'illustrates how much more still to be found'

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

How's the Capital Raise Going to Work?, page-2

Top Stories

Tuesday's HotCopper trends: Paradigm funding, Nanoveu drone gains | July 1

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Don't cry that it's over: The Reject Shop shares to disappear on Wednesday

Encounter's Aileron recon success 'illustrates how much more still to be found'

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News